🔎 Trials Near Me

Akèy › Limfom › Wisconsin › Milwaukee

Etid klinik pou Limfom nan Milwaukee, WI

9 etid pou Limfom ap chèche patisipan nan sit nan ak bò kote Milwaukee (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Ap rekriteEtid obsèvasyon
  • Children's Hospital of Wisconsin, Milwaukee
Laj 0 a 38 · Tout sèks · Mizajou Oct 1, 2026 · NCT06131801

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Ap rekriteFaz 2
  • The Medical College of Wisconsin, Milwaukee
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07221500

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Ap rekriteFaz 1/2
  • Children's Hospital of Wisconsin, Milwaukee
12 Months – 21 Years · Tout sèks · Mizajou Sep 11, 2026 · NCT04870944

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Ap rekriteFaz 1/2
  • Medical College of Wisconsin, Milwaukee
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

DALY II USA/ MB-CART2019.1 for DLBCL

Ap rekriteFaz 2
  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT04792489

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Ap rekriteFaz 1
  • Medical College of Wisconsin, Milwaukee
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT05131022

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Ap rekriteEtid obsèvasyon
  • Children's Hospital of Wisconsin, Milwaukee
Tout laj · Tout sèks · Mizajou May 18, 2026 · NCT01790152

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

Ap rekriteFaz 1
  • Froedtert & the Medical College of Wisconsin, Milwaukee
Laj 18 ak plis · Tout sèks · Mizajou Apr 3, 2026 · NCT05544968

Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab

Ap rekriteEtid obsèvasyon
  • CIBMTR, Milwaukee
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2024 · NCT04014374

Etid Limfom nan lòt vil

Lòt etid nan Milwaukee

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.